What are the current blood pressure targets for acute ischemic stroke versus acute intracerebral hemorrhage according to the latest guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Pressure Targets in Acute Ischemic vs Hemorrhagic Stroke

Blood pressure management differs fundamentally between ischemic and hemorrhagic stroke: in acute ischemic stroke, permissive hypertension is the default approach (avoiding BP lowering unless >220/120 mmHg), while in acute intracerebral hemorrhage, early aggressive reduction to systolic BP <140 mmHg is recommended to limit hematoma expansion. 1

Acute Ischemic Stroke: Permissive Hypertension Strategy

Without Reperfusion Therapy

Avoid routine BP lowering in the first 24 hours unless systolic BP exceeds 220 mmHg or diastolic BP exceeds 120 mmHg. 1 The rationale is that elevated BP may maintain cerebral perfusion to ischemic penumbra, and aggressive lowering has not demonstrated benefit for mortality or functional outcomes. 2

When BP exceeds 220/120 mmHg:

  • Reduce BP cautiously by <15% within 24 hours
  • No specific antihypertensive agent is recommended over others 1

With Intravenous Thrombolysis

Maintain BP <185/110 mmHg before thrombolytic bolus, then <180/105 mmHg during and for 24 hours after treatment. 1 This strict threshold exists to minimize hemorrhagic transformation risk.

Do NOT target intensive lowering to 130-140 mmHg during the first 72 hours, as this provides no additional benefit. 1

With Mechanical Thrombectomy

Keep BP <180/105 mmHg during and for 24 hours after the procedure. 1

Critical caveat: After successful reperfusion (mTICI grade 3), strongly avoid actively reducing systolic BP <140 mmHg in the first 24 hours (high-certainty evidence, strong recommendation against). 1 This intensive lowering likely increases mortality and reduces favorable neurologic outcomes. 2

Avoid systolic BP drops during the procedure, and do not use vasopressors for induced hypertension. 1

Acute Intracerebral Hemorrhage: Aggressive Early Control

Reduce systolic BP to <140 mmHg as rapidly as possible after hospital presentation in patients with small-to-moderate hematomas. 1 This represents expert consensus despite uncertain net clinical benefit in trials, as the goal is to limit hematoma expansion—a key driver of mortality and disability. 3

Key Differences from Ischemic Stroke:

  • Timing: Initiate BP lowering immediately upon ICH diagnosis, not delayed 3
  • Target: Systolic BP <140 mmHg (vs. permissive hypertension in ischemic stroke) 1
  • Rationale: Prevent hematoma expansion rather than maintain perfusion 3

Important Caveats:

  • Avoid excessive BP drops or large variability 4
  • Exercise particular caution when baseline systolic BP >220 mmHg 4
  • Continue oral antihypertensives if patient can swallow; use IV agents if not 1
  • Preferred IV agents include urapidil or labetalol (avoid transdermal glyceryl trinitrate) 1

Pre-Hospital Management

Do not lower BP in the ambulance for suspected stroke until brain imaging confirms stroke type. 1 This strong recommendation exists because treatment differs dramatically between ischemic and hemorrhagic stroke, and pre-hospital lowering may harm ICH patients.

Comparative Summary Table

Parameter Acute Ischemic Stroke Acute Intracerebral Hemorrhage
Default approach Permissive hypertension Early aggressive lowering
Target (no reperfusion) Avoid lowering unless >220/120 <140 mmHg systolic
Target (with reperfusion) <180/105 mmHg N/A
Timing Delay 24h unless extreme elevation Immediate upon diagnosis
Post-successful thrombectomy Avoid <140 mmHg (strong) N/A
Rationale Maintain penumbral perfusion Limit hematoma expansion

Evidence Quality and Certainty

The 2025 ESO guidelines 1 acknowledge that most recommendations carry moderate to very low certainty evidence due to inconsistent trial results and methodological limitations. The strongest evidence (high-certainty) supports avoiding intensive BP lowering <140 mmHg after successful thrombectomy. 1 For ICH, despite multiple trials, the net clinical benefit of intensive lowering remains uncertain, making the <140 mmHg target an expert consensus recommendation rather than evidence-based mandate. 1

Recent meta-analysis 2 confirms that intensive BP management in reperfused ischemic stroke results in little to no difference in clinical function but probably increases all-cause mortality (moderate-certainty evidence), reinforcing the permissive approach.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.